Table 3.
Types of medications used as recorded across all migraine records
| Type of medication, n (%) | CM (N = 10,347) | 8–14 EM (N = 11,301) | 4–7 EM (N = 6504) | Total (N = 28,152) |
|---|---|---|---|---|
| NSAIDs (acute treatment) | 2760 (26.7) | 3259 (28.8) | 2050 (31.5) | 8069 (28.7) |
| Triptans (acute treatment) | 3167 (30.6) | 4003 (35.4) | 1823 (28.0) | 8993 (31.9) |
| Acetaminophen (acute treatment) | 1825 (17.6) | 2109 (18.7) | 1388 (21.3) | 5322 (18.9) |
| Opioids (acute treatment) | 1094 (10.6) | 763 (6.8) | 514 (7.9) | 2371 (8.4) |
| Anti-epileptics (prophylactic treatment) | 703 (6.8) | 441 (3.9) | 148 (2.3) | 1292 (4.6) |
| Antihypertension and CCBs (prophylactic treatment) | 455 (4.4) | 562 (5.0) | 224 (3.4) | 1241 (4.4) |
| Antidepressant (prophylactic treatment) | 280 (2.7) | 250 (2.2) | 48 (0.7) | 578 (2.1) |
| Antinausea/antiemetic (symptomatic treatment) | 175 (1.7) | 160 (1.4) | 26 (0.4) | 361 (1.3) |
| Antihistamine (symptomatic treatment) | 262 (2.5) | 123 (1.1) | 53 (0.8) | 438 (1.6) |
| Anxiolytics (symptomatic treatment) | 114 (1.1) | 42 (0.4) | 14 (0.2) | 170 (0.6) |
| Others | 1325 (12.8) | 1403 (12.4) | 706 (10.9) | 3434 (12.2) |
| No drugs | 1871 (18.1) | 1597 (14.1) | 1022 (15.7) | 4490 (15.9) |
“Others” include drugs that do not fit in the displayed categories. “No drugs” means that the patient explicitly said they did not consume any drug. Data represent the most recent 28-day period reported by migraine patients during the study period (June 2015–July 2015). Users could indicate one or more medications during their migraine and thus numbers may not add up to 100%
CCB calcium channel blocker, CM chronic migraine, EM episodic migraine, NSAID nonsteroidal anti-inflammatory drug